The better the question. The better the answer. The better the world works. У вас есть вопрос? У нас есть ответ. Решая сложные задачи бизнеса, мы улучшаем мир. У вас є запитання? У нас є відповідь. Вирішуючи складні завдання бізнесу, ми змінюємо світ на краще. Meilleure la question, meilleure la réponse. Pour un monde meilleur. 問題越好。答案越好。商業世界越美好。 问题越好。答案越好。商业世界越美好。

If personal data becomes a new health currency, how will we prevent care inequality?

Where to find EY Life Sciences at BIO International Convention

5–7 June 2018 in Boston, MA

Rapid technological advances have made it possible to generate and disseminate data at unprecedented rates. As new technologies empower individuals to see and share their health data, they are demanding greater say over their lifelong health journey, as well as new health products and services. In this rapidly converging world, life sciences companies must consider how they will adapt and their current business models and how they will adapt to create future value.

Come hear our EY moderators and their distinguished panelists discuss the upside of this disruption including precision medicine, the rising expectations of stakeholders, the underlying drivers of consumer decision-making and more at BIO 2018, 5-7 June in Boston, MA.

Contact us

Angela Kyn
EY Life Sciences Marketing Director

Laura Powers
EY Life Sciences Media & PR

Who you’ll see from EY at BIO 2018

The following BIO 2018 panels will be moderated by EY leaders. Click on each EY leader to learn more

EY - Pamela Spence

EY’s global life sciences leader will be at BIO taking part in various networking events, meeting the media and holding conversations centered on a key question. How can tech help biotech fuse the physical, digital and biological worlds?

Pamela Spence

Global Life Sciences Industry Leader
 


EY - Kristin Pothier

Precision medicine coming of age

Kristin Pothier

Global Head of Life Sciences Strategy and Managing Director, EY-Parthenon
5 June, 11:00 a.m. –12:00 p.m.
Room 259B, Level 2
 


EY - Glen Giovannetti

Biotechnology financing, dealmaking and state of the industry: findings from EY industry analysis

Glen Giovannetti

EY Global Biotechnology Leader, EY ·
5 June, 1:45–2:45 p.m.
Room 257AB, Level 2
 


EY - Susan Garfield

What’s really driving your customer’s behavior? How cutting edge biopharmas are using behavioral economic frameworks to reach patients in a digital world

Susan Garfield

Global Commercial Life Sciences Leader, EY
5 June, 1:45–2:45 p.m.
Room 259A, Level 2
 


EY - Arda Ural

Is your growth strategy a big deal? Maximizing shareholder value in today’s high valuation environment

Arda Ural

Principal, Transaction Advisory Services, Life Sciences, EY
6 June, 11–noon
Room 257AB, Level 2
 


EY - Alex Jung

Drawing a line in the sand: rethinking pharmacy benefits

Alex Jung

Managing Director, Transaction Advisory Services, EY-Parthenon
6 June, 4:15–5:15 p.m.
Room 210A, Level 2


EY - Adlai Goldberg

Digital transformation in the life sciences

Adlai Goldberg (speaker)

Principal
7 June, 12:00 –1:00 p.m.
Room 210C, Level 2